BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210627
DTEND;VALUE=DATE:20210703
DTSTAMP:20260403T150553
CREATED:20201203T013414Z
LAST-MODIFIED:20201203T013414Z
UID:4693-1624752000-1625270399@carb-x.org
SUMMARY:Gordon Research Conference: Antimicrobial Peptides
DESCRIPTION:Additional details forthcoming. \nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/gordon-research-conference-antimicrobial-peptides/
LOCATION:Four Points Sheraton / Holiday Inn Express\, 1050 Schooner Drive\, Ventura\, CA\, 93001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210629
DTEND;VALUE=DATE:20210701
DTSTAMP:20260403T150553
CREATED:20210127T232452Z
LAST-MODIFIED:20210127T232452Z
UID:4904-1624924800-1625097599@carb-x.org
SUMMARY:ICAAR 2021: 15. International Conference on Antibiotics and Antibiotic Resistance
DESCRIPTION:The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality\, it provides an exceptional value for students\, academics and industry researchers. \nICAAR 2021: 15. International Conference on Antibiotics and Antibiotic Resistance aims to bring together leading academic scientists\, researchers and research scholars to exchange and share their experiences and research results on all aspects of Antibiotics and Antibiotic Resistance. It also provides a premier interdisciplinary platform for researchers\, practitioners and educators to present and discuss the most recent innovations\, trends\, and concerns as well as practical challenges encountered and solutions adopted in the fields of Antibiotics and Antibiotic Resistance \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/icaar-2021-15-international-conference-on-antibiotics-and-antibiotic-resistance/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210629
DTEND;VALUE=DATE:20210702
DTSTAMP:20260403T150553
CREATED:20210420T152648Z
LAST-MODIFIED:20210420T152648Z
UID:5305-1624924800-1625183999@carb-x.org
SUMMARY:6th Microbiome Movement - Drug Development Summit
DESCRIPTION:Welcome to the 6th Microbiome Movement – Drug Development Summit\, the most comprehensive forum for microbiome drug developers\, the Microbiome Movement! \nContinuing to unite the most forward thinking and industry researchers from the biopharmaceutical industry\, our unrivaled program will uncover microbiome functionality and mechanisms\, advance clinical development\, overcome the key CMC challenges\, whilst also discovering and applying microbiome biomarkers for improved clinical outcomes. This is THE must attend conference for microbiome drug developers. \nRecent clinical successes within the space are paving a way for the first FDA approved microbiome therapeutic\, however\, there still remains a number of unique scientific and practical challenges that must be overcome to pursue the causal role of the microbiome in disease\, and translate the complex science into realized and effective therapies that improve patient outcomes. \nOur end-to-end discussion will unite 65+ expert speakers and 250+ key decision-makers to provide you with valuable insights into the latest scientific discoveries and industry progress\, to help overcome the obstacles holding back therapeutic approval. This summit provides unique a platform for lasting connections with leaders at the cutting edge of making microbiome therapeutics an effective reality. \nThe 6th Microbiome Movement – Drug Development Summit is the perfect opportunity for the industry to take a collaborative approach to close the clinical gap\, discover the next generation of microbiome-based therapeutics\, and establish new partnerships to accelerate your research.  \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/6th-microbiome-movement-drug-development-summit/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210629
DTEND;VALUE=DATE:20210701
DTSTAMP:20260403T150553
CREATED:20210623T180031Z
LAST-MODIFIED:20210623T180135Z
UID:5483-1624924800-1625097599@carb-x.org
SUMMARY:Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) Virtual Public Meeting
DESCRIPTION:The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) provides advice\, information\, and recommendations to the Secretary regarding programs and policies intended to support and evaluate the implementation of U.S. government activities related to combating antibiotic-resistant bacteria.\n\n\n\n\n\n\nAt the June 29-30\, 2021 Virtual Public Meeting\, the PACCARB will deliberate and vote on two reports to transmit to the Secretary of Health and Human Services\, the first from the Disparities in Antibiotics Access and Use Working Group\, and the second from the Working Group on Antimicrobial Resistance (AMR) in Inter-Professional Education. The remainder of the 2-day public meeting will include an update on the status of the antibiotic development pipeline and an open council discussion on provocative questions in AMR (no recommendations will be made)\, in addition to presentations on Operationalizing One Health and the Environmental Dimensions of AMR. \nDate and Time:\nJune 29\, 2021 | 10:00 a.m. – 3:00 p.m. ET\nJune 30\, 2021 | 10:00 a.m. – 3:00 p.m. ET \n\n\n\n\n\nCARB-X participants include Kevin Outterson\, Executive Director\, who will be leading a session titled “THE ANTIBIOTICS PIPELINE: PAST\, PRESENT\, AND FUTURE” on June 29th at 12.05pm ET. \nClick here to learn more. \nClick here to view the agenda.\nClick here to view a live stream of the event.
URL:https://carb-x.org/event/presidential-advisory-council-on-combating-antibiotic-resistant-bacteria-paccarb-virtual-public-meeting/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210705T080000
DTEND;TZID=America/New_York:20210705T120000
DTSTAMP:20260403T150553
CREATED:20210623T175205Z
LAST-MODIFIED:20210623T175205Z
UID:5481-1625472000-1625486400@carb-x.org
SUMMARY:Advances in Antimicrobial Innovation Scientific meeting
DESCRIPTION:This Royal Society conference will bring together scientists\, medical practitioners and funding bodies to raise awareness and interest for new anti-microbial advances. \nAnti-microbial resistance continues to grow as a worldwide health challenge. Pathogens are continually evolving to combat drugs given to treat potentially life-threatening diseases\, rendering treatments ineffective and threatening the many advances in fighting microbes over recent decades. \nAs therapeutics in current use become less effective\, new approaches are required. This event aims to raise awareness and interest for new anti-microbial advances\, the challenges faced in market delivery\, and their appropriate use in healthcare systems. \nAbout the conference series:\nThe conference is part of the Royal Society’s Transforming our future conferences in the life sciences\, supported by AstraZeneca. These meetings are unique\, high-level events that address the scientific and technical challenges of the next decade. Each conference features cutting edge science from industry and academia and brings together leading experts from the scientific community\, including regulatory\, charity and funding bodies. This conference also forms part of the Academy of Medical Sciences’ FORUM programme. \nCARB-X participants include Erin Duffy\, Chief of R&D\, who will participate in the session ‘Challenges of prescribing\, diagnostics and antibiotic education\, investment and building a business model for new antibiotics’ between 3.30pm – 4.30pm EST. \nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/advances-in-antimicrobial-innovation-scientific-meeting/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210709
DTEND;VALUE=DATE:20210713
DTSTAMP:20260403T150553
CREATED:20200908T161215Z
LAST-MODIFIED:20210309T184944Z
UID:4330-1625788800-1626134399@carb-x.org
SUMMARY:31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
DESCRIPTION:We invite you to the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)\, which will take place in Vienna\, Austria and virtually from 9 – 12 July 2021. This is the first time the event will take place in summer. ECCMID\, the world’s premier Clinical Microbiology & Infectious Diseases event\, brings together experts from relevant fields to present the latest findings and developments and share their expertise. The congress will take place in the beautiful city of Vienna at the Reed Messe Conference Centre\, as well as online\, allowing us to create a unique experience to all delegates regardless of the mode of participation. The programme committee has developed a multi-faceted programme to incorporate all of the exciting educational\, social and professional events that ECCMID has to offer. \nTo learn more\, click here.\nTo view the program\, click here.\nTo register\, click here.
URL:https://carb-x.org/event/31st-european-congress-of-clinical-microbiology-infectious-diseases-eccmid/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210720T163000
DTEND;TZID=Europe/London:20210720T180000
DTSTAMP:20260403T150553
CREATED:20210623T174658Z
LAST-MODIFIED:20210623T174741Z
UID:5478-1626798600-1626804000@carb-x.org
SUMMARY:BSAC and LP Webinar: Diagnostic driven strategies for antimicrobial resistance in the UK
DESCRIPTION:BSAC Infection Clinical Dilema Series\nWebinar: Diagnostic driven strategies for antimicrobial resistance in the UK\n\nLongitude Prize is partnering with British Society for Antimicrobial Chemotherapy (BSAC) for the Infection Clinical Dilemmas webinar series. It will bring diagnostic developers together with clinicians and professional bodies working on diagnostic evaluation in and for the National Health Service (NHS) in the UK\, to build an understanding of the NHS commissioning path for AMR diagnostic tests. The event will include presentations by the Head of AMR at NHS England and National Institute for Health and Care Excellence (NICE)\, followed by an interactive ‘Ask an Expert’ session – with experts from Medicines and Healthcare products Regulatory Agency (MHRA)\, University of Oxford NIHR Community Healthcare MedTech and IVD Cooperative and clinicians – for developers to express challenges they face and ask questions about marketing access in the UK.\n\n\nThe webinar will take place on Tuesday 20th July\, 1630-1800hrs BST \nClick here to sign-up and register.
URL:https://carb-x.org/event/bsac-and-lp-webinar-diagnostic-driven-strategies-for-antimicrobial-resistance-in-the-uk/
LOCATION:WEBINAR\, Webinar\, Webinar\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210722T110000
DTEND;TZID=America/New_York:20210722T130000
DTSTAMP:20260403T150553
CREATED:20210720T161444Z
LAST-MODIFIED:20210720T161836Z
UID:5529-1626951600-1626958800@carb-x.org
SUMMARY:Innovations for Tackling Tuberculosis in the Time of COVID-19: A Two-Part Virtual Workshop
DESCRIPTION:Register now: Innovations for Tackling Tuberculosis in the Time of COVID-19: Part One of a Two-Part Workshop (July 22\, 11 AM – 1 PM ET) \nThis public workshop is the first in a two-part series that examines the innovations needed to meet the targets for ending tuberculosis (TB) set by the WHO End TB Strategy for 2030 and affirmed by the United Nations High-Level Meeting on the Fight Against Tuberculosis. The workshop will feature presentations and discussions that will consider emerging technologies in diagnostic testing and vaccine development\, improvements in TB treatment\, and how to ensure increased and sustained commitments to reach the goal of ending TB in high burden countries despite the challenges from COVID-19. \nThis first session will provide an update on the current status\, unmet needs\, and promising advances in diagnostics\, vaccines and therapeutics\, and the critical need for new business models in sustainably combating TB. \nCARB-X participants include Kevin Outterson\, Executive Director\, who will be a speaker during the workshop.  \n\n\n\nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/innovations-for-tackling-tuberculosis-in-the-time-of-covid-19-a-two-part-virtual-workshop/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210815
DTEND;VALUE=DATE:20210821
DTSTAMP:20260403T150553
CREATED:20210128T004926Z
LAST-MODIFIED:20210128T004926Z
UID:4923-1628985600-1629503999@carb-x.org
SUMMARY:Gordon Research Conference: Staphylococcal Diseases
DESCRIPTION:The description for this conference is being developed by the conference chairs. Please check back regularly for updates to this information. \nClick here to learn more.
URL:https://carb-x.org/event/gordon-research-conference-staphylococcal-diseases/
LOCATION:Grand Summit Hotel at Sunday River\, 97 Summit Road\, Newry\, ME\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210817T080000
DTEND;TZID=America/New_York:20210821T170000
DTSTAMP:20260403T150553
CREATED:20210309T185853Z
LAST-MODIFIED:20210309T185853Z
UID:5124-1629187200-1629565200@carb-x.org
SUMMARY:The World Economic Forum Special Annual Meeting - 2021 Singapore
DESCRIPTION:The World Economic Forum Special Annual Meeting 2021 in Singapore will convene on 17-20 August. The meeting follows the success of the Forum’s virtual Davos Agenda in January\, which brought together world leaders from government\, business and society. \n\n\nThe Special Annual Meeting 2021 was scheduled for 25-28 May. Although the World Economic Forum and Government of Singapore remain confident of the measures in place to ensure a safe and effective meeting\, and local transmission of COVID-19 in Singapore remains at negligible levels\, the change to the meeting’s timing reflects the international challenges in containing the pandemic. Current global travel restrictions have made planning difficult for an in-person meeting in the first half of the year. Furthermore\, differing quarantine and air transport regulations have increased the lead time necessary to ensure that participants globally can make arrangements to join. \n\n\nThe Special Annual Meeting 2021 in Singapore in August will be the first global leadership summit to address the challenges of recovering from the pandemic and laying the basis for a more inclusive and sustainable world. It will bring leaders face-to-face to focus on shaping solutions to the most pressing challenges of our times. \n\n\n“A global leadership summit needs the participation of all global stakeholders\,” said Klaus Schwab\, Founder and Executive Chairman of the World Economic Forum. “The Special Annual Meeting in Singapore in August will provide the place for leaders from business\, government and civil society to come together to address the steps for global recovery.”  \n\n\nClick here to learn more.
URL:https://carb-x.org/event/the-world-economic-forum-special-annual-meeting-2021-singapore/
LOCATION:Singapore
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210824T080000
DTEND;TZID=America/New_York:20210826T170000
DTSTAMP:20260403T150553
CREATED:20210824T161737Z
LAST-MODIFIED:20210824T161737Z
UID:5563-1629792000-1629997200@carb-x.org
SUMMARY:BIOCOM 5th AMR Conference 2021 ­– Summer Edition: AMR Briefing Sessions
DESCRIPTION:The #AMRconference is a platform for SMEs\, start-ups\, big pharma\, academia\, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market. \nThe “AMR Conference” was started in 2017 as part of the annual “Berlin Conference on Life Sciences” series which was established by BIOCOM AG twelve years ago as an event format to discuss the challenges of SME-driven innovation for the health market and to offer a platform for meeting experts from business\, science\, clinics\, finance\, regulatory affairs and intellectual property. \nEach day will offer an AMR briefing session in the afternoon (starting at 2pm CET) on a dedicated topic\, including live speakers\, high-level panel discussions\, and interactive exchange with the audience: \n\nDay 1 – Status quo & COVID-19 Impact: What has changed after one year of COVID?\nDay 2 – Financing & Investing: What’s new with funds\, incubators and accelerators?\nDay 3 – Policy & Incentives: What can we learn from best practices to go ahead?\n\nCARB-X participants include Erin Duffy\, Chief of R&D\, who is a speaker on the session “Focus on incubators and public-private accelerators in US and Europe – How they drive the AMR innovation pipeline” on Wednesday\, August 25th at 3:00 p.m. – 4:15 p.m. CEST\, and Kevin Outterson\, Executive Director\, who is a speaker on the session “What can we expect and learn from the US and UK pull incentive initiatives?” on Thursday\, August 26th at 02:00 p.m. – 03:15 p.m. CEST \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/biocom-5th-amr-conference-2021-summer-edition-amr-briefing-sessions/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210826
DTEND;VALUE=DATE:20210829
DTSTAMP:20260403T150553
CREATED:20210128T005413Z
LAST-MODIFIED:20210128T005413Z
UID:4925-1629936000-1630195199@carb-x.org
SUMMARY:Global Conference on Vaccines Research and Development
DESCRIPTION:The conference aims to empower future generations in different fields of Vaccinology to explore exciting research outcomes that lie in tune with the objectives and theme of this exciting event. It further helps you enhance your understanding of commercial\, scientific and regulatory issues that affect strategic decision making in the Vaccine Sector. \nThis global conference sets the stage for brain-storming discussions among the participants with its enriching Q&A sessions\, round table discussions and technical workshops and provides know-how of the latest methodologies and technicalities of Vaccines. Inspiring and educating talks from eminent scientists together with keynote lectures\, plenary sessions\, and video and poster presentations that span across the length and breadth of this conference. \nWe look forward to seeing you at Vaccines Conference-2021 in Paris\, France. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/global-conference-on-vaccines-research-and-development/
LOCATION:Paris\, France
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210830
DTEND;VALUE=DATE:20210902
DTSTAMP:20260403T150553
CREATED:20210714T144516Z
LAST-MODIFIED:20210714T144516Z
UID:5523-1630281600-1630540799@carb-x.org
SUMMARY:Public Workshop: Science and Regulation of Bacteriophage Therapy
DESCRIPTION:The Food and Drug Administration (FDA)\, Center for Biologics Evaluation and Research\, and the National Institutes of Health\, National Institute of Allergy and Infectious Diseases are announcing a public workshop entitled “Science and Regulation of Bacteriophage Therapy.” The purpose of the public workshop is to exchange information with the medical and scientific community about the regulatory and scientific issues associated with bacteriophage therapy. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/public-workshop-science-and-regulation-of-bacteriophage-therapy/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210831
DTEND;VALUE=DATE:20210904
DTSTAMP:20260403T150553
CREATED:20210128T005746Z
LAST-MODIFIED:20210128T005746Z
UID:4926-1630368000-1630713599@carb-x.org
SUMMARY:American Academy of Orthopaedic Surgeons (AAOS) 2021 Annual Meeting
DESCRIPTION:Click here to learn more.\nClick here to register.
URL:https://carb-x.org/event/american-academy-of-orthopaedic-surgeons-aaos-2021-annual-meeting/
LOCATION:San Diego\, California
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210915T100000
DTEND;TZID=America/New_York:20210915T110000
DTSTAMP:20260403T150553
CREATED:20210903T133040Z
LAST-MODIFIED:20210903T133040Z
UID:5579-1631700000-1631703600@carb-x.org
SUMMARY:BLUE KNIGHT™ Webinar: Antimicrobial Resistance – Breakthrough Innovation and  Breaking Barriers
DESCRIPTION:As multi-drug resistant bacteria become increasingly threatening to global public health and existing antibiotics are becoming ineffective\, the global community of public and private organizations and life science innovators are rallying around the Antimicrobial Resistance challenge. \nJohnson & Johnson Innovation has invited leading experts in the field to share their views. Why aren’t (enough) new antibiotics being developed to address the AMR challenge? What other innovations might help without increasing antibiotic resistance? \nJoin the discussion as thought leaders share their views on the challenges surrounding this global health threat and the potential solutions. \nTopics will include: \n\nPriority MDR bacterial pathogens of interest\nPotential interventions to prevent and treat MDR bacterial infections\nBarriers in the development and commercialization pathway\nThe need for policy change to address these barriers\nThe potential roles of various organizations and public-private partnerships\n\n*This program is part of BLUE KNIGHT™\, a collaboration between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA). \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/blue-knight-webinar-antimicrobial-resistance-breakthrough-innovation-and-breaking-barriers/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210921
DTEND;VALUE=DATE:20210925
DTSTAMP:20260403T150553
CREATED:20201203T014533Z
LAST-MODIFIED:20201203T014533Z
UID:4718-1632182400-1632527999@carb-x.org
SUMMARY:2021 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
DESCRIPTION:The ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance\, scheduled to take place on Sept. 1-4\, 2020 in Dublin\, Ireland\, has been cancelled due to the COVID-19 pandemic. Visit the ESCMID website for more details. The 2021 conference will take place on Sept. 21-24 in Boston\, Mass. \nCo-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID)\, this multidisciplinary meeting will address the challenges\, opportunities and current requirements for antimicrobial drug development for AMR. \nAdditional details forthcoming. \nClick here to learn more\, additional details forthcoming. 
URL:https://carb-x.org/event/2021-asm-escmid-joint-conference-on-drug-development-to-meet-the-challenge-of-antimicrobial-resistance/
LOCATION:Boston\, Venue Forthcoming\, Boston\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210927
DTEND;VALUE=DATE:20211003
DTSTAMP:20260403T150553
CREATED:20210128T005224Z
LAST-MODIFIED:20210128T005224Z
UID:4924-1632700800-1633219199@carb-x.org
SUMMARY:18th International Conference on Pseudomonas
DESCRIPTION:The scientific sessions include Genomics and gene regulation; Antimicrobial tolerance; Host-Pathogen interactions; Metabolism and Physiology; Harnessing the Potential of Pseudomonas species; Evolution and Coevolution; Ecology; and Multi-species Interactions. \nPlenary Speaker: Fiona Brinkman\, Canada\, Fellow of the Royal Society of Canada \nKeynote Speakers: Joseph Bondy-Denomy\, Paul Turner\, Barbara Kazmierczak\, Gregg Beckham\, Wei Huang\, Jenna Gallie\, Britt Koskella\, and Jessica Scoffield \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/18th-international-conference-on-pseudomonas/
LOCATION:Atlanta\, Georgia
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210928
DTEND;VALUE=DATE:20211001
DTSTAMP:20260403T150553
CREATED:20210805T182720Z
LAST-MODIFIED:20210805T182720Z
UID:5547-1632787200-1633046399@carb-x.org
SUMMARY:The Vaccines Against Shigella and ETEC (VASE) Conference
DESCRIPTION:This is an international gathering dedicated to developing Shigella and enterotoxigenic Escherichia coli (ETEC) vaccines\, hosted by PATH\, a global nonprofit dedicated to achieving health equity. \nRegistration is now open for the VASE Virtual Symposium\, which will be held online on 28 and 30 September 2021. Check out the full agenda and read the presentation abstracts. This fully virtual event will provide key updates on vaccines being developed for Shigella\, (ETEC) and other emerging diarrheal pathogens\, such as non-typhoidal Salmonella. \nClick here to learn more.
URL:https://carb-x.org/event/the-vaccines-against-shigella-and-etec-vase-conference/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210930
DTEND;VALUE=DATE:20211003
DTSTAMP:20260403T150553
CREATED:20210128T010052Z
LAST-MODIFIED:20210128T010052Z
UID:4906-1632960000-1633219199@carb-x.org
SUMMARY:North American Cystic Fibrosis Conference (NACFC) 2021
DESCRIPTION:The North American Cystic Fibrosis Conference (NACFC) is organized by the Cystic Fibrosis Foundation (CFF).  The CFF 2021 onsite medical conference will be held from September 30 – October 2\, 2021\, in San Antonio Texas.  Additional details forthcoming. \nClick here to learn more.
URL:https://carb-x.org/event/north-american-cystic-fibrosis-conference-nacfc-2021/
LOCATION:San Antonio\, Texas
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211004
DTEND;VALUE=DATE:20211016
DTSTAMP:20260403T150553
CREATED:20210805T182846Z
LAST-MODIFIED:20210805T182846Z
UID:5546-1633305600-1634342399@carb-x.org
SUMMARY:Vaccinology in Africa Course 4-15 October 2021 (Online)
DESCRIPTION:The course provides state-of-the-art teaching in both human and veterinary vaccinology\, drawing on the experience of the Jenner Institute at the University of Oxford\, The Pirbright Institute\, and this year’s African host\, the KEMRI Wellcome Trust Research Programme in Kenya.  These courses alternate between East and West Africa. In 2021\, participation is limited to attendants currently working or studying in East Africa.    Applications close 31 August 2021. \nClick here to learn more.
URL:https://carb-x.org/event/vaccinology-in-africa-course-4-15-october-2021-online/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211006T080000
DTEND;TZID=America/New_York:20211006T090000
DTSTAMP:20260403T150553
CREATED:20210921T201936Z
LAST-MODIFIED:20210921T201936Z
UID:5592-1633507200-1633510800@carb-x.org
SUMMARY:Partnership to Fight Infectious Disease - Preparing for the Next Pandemic: An International Discussion
DESCRIPTION:The Partnership to Fight Infectious Disease is convening a discussion among international experts to help inform domestic and international pandemic preparedness strategies building on lessons learned from the COVID-19 pandemic and other experiences. \nCARB-X participants include Kevin Outterson\, Executive Director\, who will moderate the discussion. \nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/partnership-to-fight-infectious-disease-preparing-for-the-next-pandemic-an-international-discussion/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211016
DTEND;VALUE=DATE:20211025
DTSTAMP:20260403T150553
CREATED:20210128T003908Z
LAST-MODIFIED:20210128T003908Z
UID:4919-1634342400-1635119999@carb-x.org
SUMMARY:ICARe Interdisciplinary Course on Antibiotics and Resistance
DESCRIPTION:The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is currently no course providing advanced instruction on antibiotics and resistance. The specific goal of ICARe is to bring leaders in academics and industry together with trained scientists at the dawn of their careers. Cutting-edge approaches for the study of resistance and antibiotic discovery will be examined. \nThe objective of ICARe is to train the next generation of scientists implicated in the study of bacterial resistance to antibiotics and the finding of new drugs.  ICARe is designed for assistant professors\, new industry scientists\, ID fellows\, and postdoctoral research associates\, as well as members from developing areas contending with the challenge of managing antibiotic resistance with limited resources. Attendance will be limited to 40 students and will reflect the global nature of the problem. \nClick here to learn more.\nClick here to view an overview of the programme.
URL:https://carb-x.org/event/icare-interdisciplinary-course-on-antibiotics-and-resistance/
LOCATION:Les Pensieres\, Annecy\, France
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211022
DTEND;VALUE=DATE:20211026
DTSTAMP:20260403T150553
CREATED:20201203T014945Z
LAST-MODIFIED:20210302T211013Z
UID:4719-1634860800-1635206399@carb-x.org
SUMMARY:ID Week 2021
DESCRIPTION:Click here to learn more\, additional details forthcoming. 
URL:https://carb-x.org/event/id-week-2021/
LOCATION:San Diego\, Venue Forthcoming\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211022T093000
DTEND;TZID=America/New_York:20211022T103000
DTSTAMP:20260403T150553
CREATED:20210819T182315Z
LAST-MODIFIED:20211001T204352Z
UID:5556-1634895000-1634898600@carb-x.org
SUMMARY:CARB-X WEBINAR: European Celebration of 5 Years of Progress with CARB-X
DESCRIPTION:European Celebration of 5 Years of Progress with CARB-X \nA virtual discussion of progress and plans to accelerate innovation globally \n22nd of October\, 2021\, 3:30 – 4:30pm CET / 9:30 – 10:30am ET  \nAntibiotic-resistance undermines the safety net for modern medicine. Chemotherapy\, surgeries\, transplantation\, childbirth – all of these and more depend on antibiotics to treat infection.  At least 700\,000 people die each year due to antibiotic-resistant (AMR) infections\, according to a recent WHO report. A recent Lancet publication from the European Center for Disease Prevention and Control (ECDC) estimates that approximately 33\,000 deaths in the EU each year can be attributed to AMR\, and an Organization of Economic Cooperation & Development OECD report calculates about 1.1 billion Euros are required for the health care systems of EU/EEA countries to address AMR. \nCARB-X and its partners are taking action. CARB-X has funded 92 projects in 12 countries totaling more than $360 million since it launched in 2016. In Europe\, the support of Wellcome Trust\, the German Ministry of Health and Education\, and the UK Global AMR Innovation Fund was critical to this progress over the past five years. \nToday\, the CARB-X portfolio is the world’s largest and most scientifically diverse antibacterial R&D portfolio. We are currently accelerating projects focused on the most serious antibiotic-resistant bacteria\, including new classes of antibiotics and non-traditional agents\, vaccines and other preventatives such as CRISPR-phage\, microbiome-modifying agents and antibodies\, and rapid diagnostics. \nPlease join us for a virtual discussion of the critical role that CARB-X and its global partners play in driving the development of innovative products to address the antibiotic-resistant bacteria health crisis. \nCARB-X Executive Director Kevin Outterson will highlight achievements\, especially in Europe and speak to CARB-X’s future vision and strategy. \nEuropean-based funders of CARB-X will outline their objectives and strategy in preparedness and how CARB-X delivery over 2016-2021 has met some of these goals. \nSeveral European product developers in the current CARB-X portfolio will speak about their innovative products and their experience working with CARB-X. \nA panel of experts will discuss antibiotics as the safety net for modern medicine and the challenges of bringing innovative products to patients in Europe. \n\nVeronika von Messling – Director-General for Life Sciences at the German Federal Ministry of Education and Research (confirmed)\nFlorence Séjourné – Chief Executive Director of Da Volterra and President of BEAM Alliance (confirmed)\nSir Jeremy Farrar – Director of Wellcome Trust & Member of the One Health Global Leaders Group on AMR (confirmed)\n Otto Cars – Founding Director of ReAct\, Senior Professor\, Infectious Diseases\, Uppsala University\, and former member of UN Inter-Agency Coordination Group on AMR (confirmed)\n\nClick here to register\, and to find out more about this important virtual meeting.
URL:https://carb-x.org/event/carb-x-webinar-european-celebration-of-5-years-of-progress-with-carb-x/
LOCATION:WEBINAR\, Webinar\, Webinar\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211024
DTEND;VALUE=DATE:20211027
DTSTAMP:20260403T150553
CREATED:20210128T004706Z
LAST-MODIFIED:20210309T190054Z
UID:4922-1635033600-1635292799@carb-x.org
SUMMARY:World Health Summit
DESCRIPTION:The World Health Summit promotes a science-driven and broad approach to global health development with the Sustainable Development Goals (SDGs) at its core. Our key issues are therefore interdisciplinary\, science-based\, cross-sectoral\, and concerted. They are vital to set the global health agenda for the years to come. Because health is more than medicine and health is a human right. Key issues include: \n\nAccess to Essential Medicine\nBig Data\nBiomedical Research\nClimate Change and Health\nDigital Innovation\nDrugs and Vaccines\nEvolutionary Medicine\nGlobal Action Plan for Healthy Lives and Well-being for All\nGlobal Health Security\nHealth in All Policies\nHealth Systems Strengthening\nPandemic Preparedness\nPatient Safety\nPlanetary Health\nSustainable Development Goals (SDGs)\nTranslational Science\nUniversal Health Coverage\n\nClick here to learn more.
URL:https://carb-x.org/event/world-health-summit/
LOCATION:Berlin\, Germany
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211103
DTEND;VALUE=DATE:20211105
DTSTAMP:20260403T150553
CREATED:20210128T004148Z
LAST-MODIFIED:20210518T183536Z
UID:4920-1635897600-1636070399@carb-x.org
SUMMARY:BARDA Industry Day
DESCRIPTION:BARDA Industry Day is the annual meeting held to increase potential partner’s awareness of U.S. Government medical countermeasure priorities\, interact with BARDA and ASPR staff\, and network with public and private sector colleagues working in the Health Security space. \nAdditional details forthcoming.
URL:https://carb-x.org/event/barda-industry-day-3/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211108
DTEND;VALUE=DATE:20211110
DTSTAMP:20260403T150553
CREATED:20201203T015107Z
LAST-MODIFIED:20211101T152552Z
UID:4720-1636329600-1636502399@carb-x.org
SUMMARY:World Antimicrobial Resistance Congress 2021
DESCRIPTION:Antimicrobial resistance (AMR) is one of the biggest global health crises facing the world today. The number of deaths attributed to AMR is expected to surpass the number of deaths from cancer worldwide by 2050. Yet combatting resistance globally and developing a robust arsenal of antibiotics continues to fall behind the pace of resistance.\nSince 2015\, the World Anti-Microbial Resistance Congress has been the go-to conference globally for all stakeholders in the AMR space to meet\, brainstorm ideas and formulate initiatives that can effectively tackle this pressing issue. \nIndustry leaders\, innovative technology and solution providers\, public authorities\, international organizations\, infectious disease clinicians\, pharmacists and microbiologists are some of the 1\,000+ attendees from over 50 countries who will gather this November 2021 at the World Anti-Microbial Resistance Congress. \nThe conference will gather global leaders in infectious diseases to meet\, brainstorm and discuss the challenges and opportunities on the following areas: \n\nAdvancing antibiotic R&D and non-traditional therapies development\nEnhancing the commercial landscape and marketplace for antibiotics and diagnostics\nDeveloping innovative diagnostics solutions\nFacilitating interactions between funders and developers\nImproving antimicrobial stewardship guidelines and practice through technology\nImplementing sustainable environmental and manufacturing practices\nTackling infection control at hospitals efficiently and cost-effectively\nApplying genomics to easily detect resistant pathogens and to accelerate antibiotic R&D\nLeveraging surveillance platforms and solutions to monitor outbreaks and increasing numbers of resistant pathogens locally\, regionally\, nationally and globally.\n\nIf you work in these key areas of AMR\, then you must attend the World Anti-Microbial Resistance Congress 2021! \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/world-amr-congress-2021/
LOCATION:Washington DC
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211114
DTEND;VALUE=DATE:20211119
DTSTAMP:20260403T150553
CREATED:20210128T002137Z
LAST-MODIFIED:20210128T002137Z
UID:4907-1636848000-1637279999@carb-x.org
SUMMARY:9th ASM Conference on Biofilms
DESCRIPTION:The 9th ASM Conference on Biofilms will be coming to Charlotte\, N.C. on Nov. 14 –18\, 2021.  Additional Details Forthcoming. \nBiofilms have a tremendous impact on industrial\, clinical and natural environments. 2021 ASM Biofilms will provide an interdisciplinary platform to discuss the latest biofilm research. Check back later for more details about the meeting. We look forward to seeing you next year. \nClick here to learn more.\nClick here to view the agenda.
URL:https://carb-x.org/event/9th-asm-conference-on-biofilms/
LOCATION:Charlotte\, North Carolina
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211115
DTEND;VALUE=DATE:20211117
DTSTAMP:20260403T150553
CREATED:20210127T235230Z
LAST-MODIFIED:20210127T235230Z
UID:4908-1636934400-1637107199@carb-x.org
SUMMARY:3rd SCI-RSC Symposium on Antimicrobial Drug Discovery
DESCRIPTION:At a time when antimicrobial resistance is decreasing the efficacy of existing treatments\, it has never been more important that we refresh the drug pipeline with new therapeutics acting on new targets or exhibiting novel modes of action.\nFortunately\, renewed interest from both industry and academia has led to a resurgence in antimicrobial drug discovery and interest in developing innovative technologies and approaches for combating infection. \nCoinciding with WHO’s World Antibiotics Awareness week\, this two-day meeting will examine the latest advances in antimicrobial drug discovery from a medicinal chemist’s perspective\, focusing on the particular challenges associated with developing antimicrobials whilst also showcasing emerging strategies for tackling infection. \nBringing together leading exponents in the field from industry and academia\, the meeting will appeal to anyone with an interest in antimicrobial resistance and antimicrobial drug discovery. And with great opportunities for academic–industrial partnerships\, researchers from both sectors will also benefit from the networking opportunities that the meeting will offer. \nClick here to learn more.\nEmail conferences@soci.org to register your interest. \nConference Team\nTel: +44 (0)20 7598 1561\nEmail: conferences@soci.org
URL:https://carb-x.org/event/3rd-sci-rsc-symposium-on-antimicrobial-drug-discovery/
LOCATION:SCI\, 14/15 Belgrave Square\, London\, SW1X 8PS\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211116T080000
DTEND;TZID=America/New_York:20211116T093000
DTSTAMP:20260403T150553
CREATED:20211014T205847Z
LAST-MODIFIED:20211014T205847Z
UID:5629-1637049600-1637055000@carb-x.org
SUMMARY:EFPIA - Pandemic Prevention: how Europe can lead the fight against AMR
DESCRIPTION:You’re invited to join this virtual event on Tuesday\, 16 November\, 2021 at 14:00 – 15:30 CET. \nThe COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not.\nThe World Bank estimates that 10 million people per year could die if new antimicrobials are not found. Without effective prevention and treatment of infections\, medical procedures such as organ transplantation\, cancer chemotherapy\, and major surgery will become too dangerous to perform. In the Pharmaceutical Strategy for Europe\, the European Commission declared that “new business models are required” if we are to meet this challenge and succeed\, spotlighting 2022 as the year when change needs to happen.\n\nJoin us to discuss how we can drive investment in antimicrobials R&D and set out a roadmap to a sustainable innovation ecosystem that will safeguard society against the threat of AMR.\n  \nCARB-X participants include Kevin Outterson\, Executive Director. \nClick here to learn more and register.
URL:https://carb-x.org/event/efpia-pandemic-prevention-how-europe-can-lead-the-fight-against-amr/
LOCATION:VIRTUAL EVENT
END:VEVENT
END:VCALENDAR